×
About 912 results

ALLMedicine™ Sinus Node Dysfunction Center

Research & Reviews  447 results

Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and ...
https://doi.org/10.1007/s10741-021-10080-2 10.1073/pnas.75.9.4499 10.1172/JCI111390 10.1111/jns.12153 10.3109/13506129.2015.1135792 10.1080/13506129.2018.1519507 10.1016/j.jacc.2018.07.092 10.1016/j.jhsa.2019.06.016 10.2169/internalmedicine.46.6008 10.1007/s00415-019-09671-9 10.1056/NEJMoa1716153 10.1056/NEJMoa1716793 10.1056/NEJMoa1805689 10.1080/13506129.2020.1730790 10.1185/03007995.2012.754348 10.1016/j.jacc.2016.03.596 10.1161/CIRCULATIONAHA.111.078915 10.1093/eurheartj/ehs123 10.1002/humu.22619 10.1186/1750-1172-8-31 10.1038/s41467-019-13038-z 10.1186/1750-1172-10-S1-O26 10.1186/1750-1172-10-S1-P22 10.1136/jnnp-2016-315262 10.1080/13506129.2019.1672649 10.1093/eurheartj/ehv338 10.1161/CIRCHEARTFAILURE.119.006075 10.1016/j.cjca.2016.05.008 10.1186/s12875-020-01252-4 10.1093/eurheartj/ehv583 10.1016/j.ahj.2012.04.015 10.1016/j.amjcard.2011.03.040 10.1016/j.cardfail.2016.10.008 10.1007/s10741-014-9462-7 10.1161/CIRCULATIONAHA.115.018852 10.1016/j.jchf.2013.11.004 10.1016/j.jchf.2019.04.010 10.1212/WNL.0000000000005777 10.1001/archneur.1969.00480110054005 10.1002/mus.21332 10.1002/mus.25257 10.1136/jnnp-2015-310907 10.1177/1756285612470192 10.1007/s10286-018-0514-2 10.1002/mus.20821 10.1111/j.1751-7133.2009.00058.x 10.1186/1750-1172-9-61 10.3233/JND-150091 10.1016/j.cardfail.2017.12.005 10.1016/j.humpath.2011.03.004 10.1016/j.humpath.2010.11.017 10.1161/JAHA.113.000098 10.1038/modpathol.2014.102 10.1001/jama.2017.9236 10.1080/13506129.2017.1375908 10.1016/j.jacc.2019.04.003 10.1161/CIR.0000000000000792 10.1136/heartjnl-2015-308657 10.1136/jnnp-2011-301299 10.1002/mus.26515 10.1016/S1474-4422(12)70065-0 10.3389/fendo.2019.00929
Heart Failure Reviews; Nativi-Nicolau JN, Karam C et. al.

Feb 20th, 2021 - Amyloid transthyretin (ATTR) amyloidosis is a clinically heterogeneous and fatal disease that results from deposition of insoluble amyloid fibrils in various organs and tissues, causing progressive loss of function. The objective of this review is...

Multiple arrhythmic and cardiomyopathic phenotypes associated with an SCN5A A735E mutat...
https://doi.org/10.1016/j.jelectrocard.2021.01.019
Journal of Electrocardiology; Sasaki T, Ikeda K et. al.

Feb 20th, 2021 - SCN5A mutations are associated with multiple arrhythmic and cardiomyopathic phenotypes including Brugada syndrome (BrS), sinus node dysfunction (SND), atrioventricular block, supraventricular tachyarrhythmias (SVTs), long QT syndrome (LQTS), dilat...

Retrieval of a leadless transcatheter pacemaker from the right pulmonary artery: A case...
https://doi.org/10.1111/pace.14135
Pacing and Clinical Electrophysiology : PACE; Romeo E, D'Alto M et. al.

Dec 7th, 2020 - This case report describes a procedure of retrieval of a leadless transcatheter pacemaker from the right pulmonary artery 3 days after device implantation. An 80-year-old man affected by ischemic cardiomyopathy and sinus node dysfunction was impla...

MOST but only almost: Are leadless pacemakers appropriate in sinus node dysfunction?
https://doi.org/10.1111/pace.14096
Pacing and Clinical Electrophysiology : PACE REFERENCES; Lau CP

Oct 21st, 2020 - MOST but only almost: Are leadless pacemakers appropriate in sinus node dysfunction?|2020|Lau CP,|

VVI pacing with normal QRS duration and ventricular function: MOST trial findings relev...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744322
Pacing and Clinical Electrophysiology : PACE; Loring Z, North R et. al.

Oct 21st, 2020 - Leadless pacemakers (LPs) provide ventricular pacing without the risks associated with transvenous leads and device pockets. LPs are appealing for patients who need pacing, but do not need defibrillator or cardiac resynchronization therapy. Most i...

see more →

Clinicaltrials.gov  459 results

Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and ...
https://doi.org/10.1007/s10741-021-10080-2 10.1073/pnas.75.9.4499 10.1172/JCI111390 10.1111/jns.12153 10.3109/13506129.2015.1135792 10.1080/13506129.2018.1519507 10.1016/j.jacc.2018.07.092 10.1016/j.jhsa.2019.06.016 10.2169/internalmedicine.46.6008 10.1007/s00415-019-09671-9 10.1056/NEJMoa1716153 10.1056/NEJMoa1716793 10.1056/NEJMoa1805689 10.1080/13506129.2020.1730790 10.1185/03007995.2012.754348 10.1016/j.jacc.2016.03.596 10.1161/CIRCULATIONAHA.111.078915 10.1093/eurheartj/ehs123 10.1002/humu.22619 10.1186/1750-1172-8-31 10.1038/s41467-019-13038-z 10.1186/1750-1172-10-S1-O26 10.1186/1750-1172-10-S1-P22 10.1136/jnnp-2016-315262 10.1080/13506129.2019.1672649 10.1093/eurheartj/ehv338 10.1161/CIRCHEARTFAILURE.119.006075 10.1016/j.cjca.2016.05.008 10.1186/s12875-020-01252-4 10.1093/eurheartj/ehv583 10.1016/j.ahj.2012.04.015 10.1016/j.amjcard.2011.03.040 10.1016/j.cardfail.2016.10.008 10.1007/s10741-014-9462-7 10.1161/CIRCULATIONAHA.115.018852 10.1016/j.jchf.2013.11.004 10.1016/j.jchf.2019.04.010 10.1212/WNL.0000000000005777 10.1001/archneur.1969.00480110054005 10.1002/mus.21332 10.1002/mus.25257 10.1136/jnnp-2015-310907 10.1177/1756285612470192 10.1007/s10286-018-0514-2 10.1002/mus.20821 10.1111/j.1751-7133.2009.00058.x 10.1186/1750-1172-9-61 10.3233/JND-150091 10.1016/j.cardfail.2017.12.005 10.1016/j.humpath.2011.03.004 10.1016/j.humpath.2010.11.017 10.1161/JAHA.113.000098 10.1038/modpathol.2014.102 10.1001/jama.2017.9236 10.1080/13506129.2017.1375908 10.1016/j.jacc.2019.04.003 10.1161/CIR.0000000000000792 10.1136/heartjnl-2015-308657 10.1136/jnnp-2011-301299 10.1002/mus.26515 10.1016/S1474-4422(12)70065-0 10.3389/fendo.2019.00929
Heart Failure Reviews; Nativi-Nicolau JN, Karam C et. al.

Feb 20th, 2021 - Amyloid transthyretin (ATTR) amyloidosis is a clinically heterogeneous and fatal disease that results from deposition of insoluble amyloid fibrils in various organs and tissues, causing progressive loss of function. The objective of this review is...

Multiple arrhythmic and cardiomyopathic phenotypes associated with an SCN5A A735E mutat...
https://doi.org/10.1016/j.jelectrocard.2021.01.019
Journal of Electrocardiology; Sasaki T, Ikeda K et. al.

Feb 20th, 2021 - SCN5A mutations are associated with multiple arrhythmic and cardiomyopathic phenotypes including Brugada syndrome (BrS), sinus node dysfunction (SND), atrioventricular block, supraventricular tachyarrhythmias (SVTs), long QT syndrome (LQTS), dilat...

Retrieval of a leadless transcatheter pacemaker from the right pulmonary artery: A case...
https://doi.org/10.1111/pace.14135
Pacing and Clinical Electrophysiology : PACE; Romeo E, D'Alto M et. al.

Dec 7th, 2020 - This case report describes a procedure of retrieval of a leadless transcatheter pacemaker from the right pulmonary artery 3 days after device implantation. An 80-year-old man affected by ischemic cardiomyopathy and sinus node dysfunction was impla...

MOST but only almost: Are leadless pacemakers appropriate in sinus node dysfunction?
https://doi.org/10.1111/pace.14096
Pacing and Clinical Electrophysiology : PACE REFERENCES; Lau CP

Oct 21st, 2020 - MOST but only almost: Are leadless pacemakers appropriate in sinus node dysfunction?|2020|Lau CP,|

VVI pacing with normal QRS duration and ventricular function: MOST trial findings relev...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744322
Pacing and Clinical Electrophysiology : PACE; Loring Z, North R et. al.

Oct 21st, 2020 - Leadless pacemakers (LPs) provide ventricular pacing without the risks associated with transvenous leads and device pockets. LPs are appealing for patients who need pacing, but do not need defibrillator or cardiac resynchronization therapy. Most i...

see more →

News  4 results

A 67-Year-Old Man With Palpitations and Syncope
https://reference.medscape.com/viewarticle/908904_5

Feb 18th, 2019 - Advancing age is associated with an increase in the collagen content of the sinus node.[10] Age is also associated with an increase in the sinoatrial conduction time, another manifestation of sinus node dysfunction. Of note, patients with age-rela...

Bradycardia and Cardiac Conduction Delay: Clinical Practice Guidelines (2018)
https://reference.medscape.com/viewarticle/905956

Dec 4th, 2018 - The guidelines on the evaluation and management of bradycardia and cardiac conduction delay were released in November 2018 by the ACC, AHA, and HRS.[1,2] Sinus node dysfunction is most often related to age-dependent progressive fibrosis of the sin...

Two-Chamber Pacing Comes of Age
https://www.medpagetoday.com/cardiology/arrhythmias/33990

Jul 30th, 2012 - Action Points A new joint consensus statement recommends dual-chamber over single-chamber pacing, especially for patients with sinus node dysfunction and intact atrioventricular conduction. Note that this consensus statement recommends which type ...

More Bad News for Chronic RV Pacing: MOST Substudy Finds Less Is More
https://www.medscape.com/viewarticle/457912

Jun 29th, 2003 - June 30, 2003 - Recent data add weight to the argument that chronic right ventricular pacing in the dual chamber rate modulated (DDDR) mode produces poor outcomes. The latest findings from a substudy of the MOdeSelection Trial (MOST) indicate that...

see more →

Patient Education  2 results see all →